Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2013

Open Access 01-04-2013 | Original Article

Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy

Authors: Yoshihiro Yamamoto, Yoshiyuki Hiki, Shigeru Nakai, Koichiro Yamamoto, Kazuo Takahashi, Shigehisa Koide, Kazutaka Murakami, Makoto Tomita, Midori Hasegawa, Shiro Kawashima, Satoshi Sugiyama, Yukio Yuzawa

Published in: Clinical and Experimental Nephrology | Issue 2/2013

Login to get access

Abstract

Background

To clarify the therapeutic impact of tonsillectomy and combined therapies of tonsillectomy plus steroid on the long-term prognosis of immunoglobulin A nephropathy (IgAN).

Methods

A retrospective study was conducted on 208 patients with IgAN between 1986 and 2009. According to the strategies for treatments, patients were divided into four groups: tonsillectomy and steroid pulse (TSP, n = 47), tonsillectomy and oral steroid (TOS, n = 33), tonsillectomy alone (T, n = 56), and N group (no particular therapy, n = 72). Multivariate analysis based on the Cox’s regression model was used to assess the relative risk of reaching the outcome of doubling creatinine based on the influence of baseline prognostic factors.

Results

The mean observation periods were 53.8 months in the TSP group, 122.0 months in the TOS group, 102.9 months in the T group, and 84.6 months in the N group. During an observation period, serum creatinine levels doubled as follows: one in the TSP group (2.1 %), two in the TOS group (6.1 %), five in the T group (8.9 %), histological severity, and 22 in the N group (30.6 %). The Cox’s regression proportional hazard model showed that gender, age, histological activity, dialysis induction risk and therapy were associated with doubling creatinine levels. Hazard ratios (95 % CI) and (P value) in T, TOS, and TSP groups versus N were 0.314 (0.11–0.93, P = 0.037), 0.213 (0.04–1.10, P = 0.065), and 0.032 (0.00–0.28, P = 0.002), respectively.

Conclusion

A combination therapy of tonsillectomy and steroid pulse had the most significant therapeutic impact compared to other therapies.
Literature
1.
go back to reference D‘Amico G. The commonest glomerulonephrites in the world. IgA nephropathy. Q J Med. 1987;64:709–27. D‘Amico G. The commonest glomerulonephrites in the world. IgA nephropathy. Q J Med. 1987;64:709–27.
2.
go back to reference Levy M, Berger J. Worldwide prospective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.PubMed Levy M, Berger J. Worldwide prospective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.PubMed
3.
go back to reference Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research group on progressive renal diseases. Am J Kidney Dis. 1997;29:526–32.PubMedCrossRef Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research group on progressive renal diseases. Am J Kidney Dis. 1997;29:526–32.PubMedCrossRef
4.
go back to reference Donadio JV, Grade JP. IgA nephropathy. N Engl J Med. 2002;347:738–48. Donadio JV, Grade JP. IgA nephropathy. N Engl J Med. 2002;347:738–48.
5.
go back to reference Strippoli GF, Manno C, Schena FP. An “evidence-based” survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis. 2003;41:1129–39.PubMedCrossRef Strippoli GF, Manno C, Schena FP. An “evidence-based” survey of therapeutic options for IgA nephropathy: assessment and criticism. Am J Kidney Dis. 2003;41:1129–39.PubMedCrossRef
6.
go back to reference Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Cochrane Database Syst Rev. 2003;CD003965. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Cochrane Database Syst Rev. 2003;CD003965.
7.
go back to reference Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, Narita I, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003;63:1861–7.PubMedCrossRef Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, Narita I, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003;63:1861–7.PubMedCrossRef
8.
go back to reference Pozzi C, Bolasco PG, Fogazzi GB, Andulli S, Altieri P, Ponticelli C, et al. Corticosteroids in IgA nephropathy. A randomized controlled trial. Lancet. 1999;353:883–7.PubMedCrossRef Pozzi C, Bolasco PG, Fogazzi GB, Andulli S, Altieri P, Ponticelli C, et al. Corticosteroids in IgA nephropathy. A randomized controlled trial. Lancet. 1999;353:883–7.PubMedCrossRef
9.
go back to reference Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy. Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.PubMedCrossRef Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy. Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157–63.PubMedCrossRef
10.
go back to reference Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guideline for immunoglobulin A (IgA) nephropathy in Japan, 3rd version. Jpn J Nephrol. 2011;53(2):123–35. Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guideline for immunoglobulin A (IgA) nephropathy in Japan, 3rd version. Jpn J Nephrol. 2011;53(2):123–35.
11.
go back to reference Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q J Med. 1986;234:935–43. Kobayashi Y, Fujii K, Hiki Y, Tateno S. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q J Med. 1986;234:935–43.
12.
go back to reference Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significanctly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.PubMedCrossRef Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significanctly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.PubMedCrossRef
13.
go back to reference Akagi H, Fukushima K, Kosaka M, Doi A, Okano M, Kariya S, et al. A 10-year retrospective case–control study for IgA nephropathy after tonsillectomy. Int Congr Ser. 2003;1257:147–50. Akagi H, Fukushima K, Kosaka M, Doi A, Okano M, Kariya S, et al. A 10-year retrospective case–control study for IgA nephropathy after tonsillectomy. Int Congr Ser. 2003;1257:147–50.
14.
go back to reference Katafuchi R, Ninomiya T, Mizumasa T, Ikeda K, Kumagai H, Nagata M, et al. The improvement of renal survival with steroid pulse therapy in IgA nephropathy. Nephrol Dial Transplant. 2008;23:3915–20.PubMedCrossRef Katafuchi R, Ninomiya T, Mizumasa T, Ikeda K, Kumagai H, Nagata M, et al. The improvement of renal survival with steroid pulse therapy in IgA nephropathy. Nephrol Dial Transplant. 2008;23:3915–20.PubMedCrossRef
Metadata
Title
Comparison of effective impact among tonsillectomy alone, tonsillectomy combined with oral steroid and with steroid pulse therapy on long-term outcome of immunoglobulin A nephropathy
Authors
Yoshihiro Yamamoto
Yoshiyuki Hiki
Shigeru Nakai
Koichiro Yamamoto
Kazuo Takahashi
Shigehisa Koide
Kazutaka Murakami
Makoto Tomita
Midori Hasegawa
Shiro Kawashima
Satoshi Sugiyama
Yukio Yuzawa
Publication date
01-04-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0679-2

Other articles of this Issue 2/2013

Clinical and Experimental Nephrology 2/2013 Go to the issue